Delivery Order SPE2DR25D2208-SPE2DR26FB4VX
- Not listed
- The Defense Logistics Agency awarded a $2,135.94 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units, with a completion date of September 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $2,644.06 to AmerisourceBergen Drug Corp for the procurement of Lidocaine 5% Patch 30s, with an ultimate completion date of September 12, 2025. This competitive, firm fixed-price delivery order was issued on September 11, 2025, with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,654.12 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on a full and open basis. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc....
- The Defense Logistics Agency awarded a delivery order valued at $5,534.53 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of December 17, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,722.08 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lidocaine 5% Patch 30s, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.21 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of January 16, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,357.45 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of November 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,977.28 to AmerisourceBergen Drug Corp for 30 units of Lidocaine 5% Patch. This firm fixed-price, competitively awarded contract (no set-aside used) is set for completion by January 8, 2026, with performance occurring at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs...
- The Defense Logistics Agency awarded a $12,357.75 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of December 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,551.33 by the Defense Logistics Agency on January 20, 2026, for the supply of Lidocaine 5% Patch (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 21, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate office and...
- SPE2DR25D2208Indefinite Delivery Contract
- SPE2DR25D2208-SPE2DR26FB4VXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,327.82 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with a completion date of January 21, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's supply chain. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of medications, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. This structure allows AmerisourceBergen to efficiently fulfill government contracts for essential pharmaceutical products required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/19/26 |